<VariationArchive VariationID="2426770" VariationName="NC_000006.11:g.(?_79650410)_(80912949_?)del" VariationType="Deletion" Accession="VCV002426770" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1950307" VariationID="2426770">
      <GeneList>
        <Gene Symbol="BCKDHB" FullName="branched chain keto acid dehydrogenase E1 subunit beta" GeneID="594" HGNC_ID="HGNC:987" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="80106610" stop="80466676" display_start="80106610" display_stop="80466676" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80816343" stop="81055986" display_start="80816343" display_stop="81055986" Strand="+" />
          </Location>
          <OMIM>248611</OMIM>
        </Gene>
        <Gene Symbol="ELOVL4" FullName="ELOVL fatty acid elongase 4" GeneID="6785" HGNC_ID="HGNC:14415" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="79914814" stop="79947553" display_start="79914814" display_stop="79947553" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80624528" stop="80657314" display_start="80624528" display_stop="80657314" Strand="-" />
          </Location>
          <OMIM>605512</OMIM>
        </Gene>
        <Gene Symbol="HMGN3" FullName="high mobility group nucleosomal binding domain 3" GeneID="9324" HGNC_ID="HGNC:12312" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="79201245" stop="79234682" display_start="79201245" display_stop="79234682" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="79910961" stop="79944454" display_start="79910961" display_stop="79944454" Strand="-" />
          </Location>
          <OMIM>604502</OMIM>
        </Gene>
        <Gene Symbol="LCA5" FullName="lebercilin LCA5" GeneID="167691" HGNC_ID="HGNC:31923" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="79484991" stop="79538782" display_start="79484991" display_stop="79538782" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80194707" stop="80247146" display_start="80194707" display_stop="80247146" Strand="-" />
          </Location>
          <OMIM>611408</OMIM>
        </Gene>
        <Gene Symbol="LINC01621" FullName="long intergenic non-protein coding RNA 1621" GeneID="89758" HGNC_ID="HGNC:14109" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="79803583" stop="79812246" display_start="79803583" display_stop="79812246" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80513303" stop="80580136" display_start="80513303" display_stop="80580136" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="PHIP" FullName="pleckstrin homology domain interacting protein" GeneID="55023" HGNC_ID="HGNC:15673" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="78934419" stop="79078254" display_start="78934419" display_stop="79078254" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="79644135" stop="79788010" display_start="79644135" display_stop="79788010" Strand="-" />
          </Location>
          <OMIM>612870</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PHIP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PHIP">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SH3BGRL2" FullName="SH3 domain binding glutamate rich protein like 2" GeneID="83699" HGNC_ID="HGNC:15567" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="79537633" stop="79703655" display_start="79537633" display_stop="79703655" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80340999" stop="80413368" display_start="80340999" display_stop="80413368" Strand="+" />
          </Location>
          <OMIM>615678</OMIM>
        </Gene>
        <Gene Symbol="TTK" FullName="TTK protein kinase" GeneID="7272" HGNC_ID="HGNC:12401" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>6q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="80004649" stop="80042527" display_start="80004649" display_stop="80042527" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="80714321" stop="80752243" display_start="80714321" display_stop="80752243" Strand="+" />
          </Location>
          <OMIM>604092</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.11:g.(?_79650410)_(80912949_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="79650410" innerStop="80912949" display_start="79650410" display_stop="80912949" variantLength="1262540" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_79650410)_(80912949_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_79650410)_(80912949_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.11:g.(?_79650410)_(80912949_?)del AND not provided" Accession="RCV003111506" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classifications from unflagged records</ReviewStatus>
            <Description SubmissionCount="1">no classifications from unflagged records</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000006.11:g.(?_79650410)_(80912949_?)del AND Maple syrup urine disease" Accession="RCV003122618" Version="3">
        <ClassifiedConditionList TraitSetID="6467">
          <ClassifiedCondition DB="MedGen" ID="C0024776">Maple syrup urine disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-13" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16786533</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22593002</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24571530</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6467" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2822" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Maple syrup urine disease</ElementValue>
                <XRef ID="Maple+syrup+urine+disease/4453" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009563" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS248600" DB="OMIM" />
                <XRef ID="511" DB="Orphanet" />
                <XRef ID="27718001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MSUD</ElementValue>
                <XRef Type="MIM" ID="248600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Maple syrup urine disease (MSUD) is categorized as classic (severe), intermediate, or intermittent. Neonates with classic MSUD are born asymptomatic but without treatment follow a predictable course: 12â€“24 hours. Elevated concentrations of branched-chain amino acids (BCAAs; leucine, isoleucine, and valine) and alloisoleucine, as well as a generalized disturbance of amino acid concentration ratios, are present in blood and the maple syrup odor can be detected in cerumen; Two to three days. Early and nonspecific signs of metabolic intoxication (i.e., irritability, hypersomnolence, anorexia) are accompanied by the presence of branched-chain alpha-ketoacids, acetoacetate, and beta-hydroxybutyrate in urine; Four to six days. Worsening encephalopathy manifests as lethargy, apnea, opisthotonos, and reflexive "fencing" or "bicycling" movements as the sweet maple syrup odor becomes apparent in urine; Seven to ten days. Severe intoxication culminates in critical cerebral edema, coma, and central respiratory failure. Individuals with intermediate MSUD have partial branched-chain alpha-ketoacid dehydrogenase deficiency that manifests only intermittently or responds to dietary thiamine therapy; these individuals can experience severe metabolic intoxication and encephalopathy in the face of sufficient catabolic stress. In the era of newborn screening (NBS), the prompt initiation of treatment of asymptomatic infants detected by NBS means that most individuals who would have developed neonatal manifestations of MSUD remain asymptomatic with continued treatment compliance.</Attribute>
                <XRef ID="NBK1319" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000519087" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528449" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528448" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521391" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505096" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505125" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561777" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3228" />
                <XRef ID="3228" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301495</ID>
                <ID Source="BookShelf">NBK1319</ID>
              </Citation>
              <Citation Type="general" Abbrev="GMDI/SERC, 2014">
                <ID Source="PubMed">24881969</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/129/MSUD%20Nutrition%20Guidelines/Version%201.58</URL>
                <CitationText>MSUD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Leucine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased Leucine, Maple Syrup Urine Disease, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Leucine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Leucine Elevated, 2021</CitationText>
              </Citation>
              <XRef ID="511" DB="Orphanet" />
              <XRef ID="C0024776" DB="MedGen" />
              <XRef ID="D008375" DB="MeSH" />
              <XRef ID="MONDO:0009563" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS248600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7075735" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_022726.3_6_Deletion (entire coding sequence)|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003791928" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-13">
          <ReviewStatus>flagged submission</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24571530</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the ELOVL4 gene has been identified. Loss-of-function variants in ELOVL4 are known to be pathogenic (PMID: 24571530). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with ELOVL4-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ELOVL4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_79650410)_(80912949_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment DataSource="NCBI" Type="FlaggedComment">Reason: This record appears to be redundant with a more recent record from the same submitter.</Comment>
        <Comment DataSource="NCBI" Type="FlaggedComment">Notes: SCV003791928 appears to be redundant with SCV003797039.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7076634" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_183050.2_6_Deletion (exons 1-8)|MedGen:C0024776" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003797039" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16786533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22593002</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1-8 of the BCKDHB gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BCKDHB are known to be pathogenic (PMID: 16786533, 22593002). This variant has not been reported in the literature in individuals affected with BCKDHB-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BCKDHB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_79650410)_(80912949_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024776" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7075735" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7076634" TraitType="Disease" MappingType="XRef" MappingValue="C0024776" MappingRef="MedGen">
        <MedGen CUI="C0024776" Name="Maple syrup urine disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

